Stocks
Evolent Health (EVH) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 6.13% | 3.24% | -1.26% | 3.32% | -19.3% | -17.0% | ||
| Changes by years, y/y, % | +30pp | -3pp | -4pp | +5pp | -23pp | -4.0% | |||
Evolent Health. EBITDA margin, %
Evolent Health. EBITDA margin, changes, pp
Evolent Health (EVH) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -5.94% | 2.87% | 3.03% | -76.8% | 2.30% | -17.0% | |
| Changes by years, y/y, % | -9pp | -3pp | +1pp | -79pp | +8pp | |||
| Changes by quarters, q/q, % | -8pp | +9pp | +0pp | -80pp | +79pp | |||
